
West Pharmaceutical Services, Inc.
WST institutional ownership changes in Q2 2026: 160 institutions opened or added positions, 139 trimmed or exited. WST (West Pharmaceutical Services, Inc.) is held by 290 institutional investors as of Q2 2026. Top institutional shareholders: BlackRock, Inc. ($2.4B), Vanguard Capital Management LLC ($1.7B), Vanguard Portfolio Management LLC ($1.4B). Net institutional sentiment: Mixed.
Who's Trading
Latest move
Source dates: Price Nov 5, 2026 · Insiders Sep 15, 2026 · Activists Nov 5, 2026 · Congress Aug 13, 2025
Top Holders
Showing 1-20 of 302
Continue exploring
Other Healthcare stocks held by institutions
Questions investors ask about WST
Who owns WST?
290 institutional investors held WST on June 30, 2026, led by BlackRock, Inc. ($2.4B), Vanguard Capital Management LLC ($1.7B) and Vanguard Portfolio Management LLC ($1.4B).
How many hedge funds hold WST?
290 institutional investors reported WST in their 13F filings for the quarter ended June 30, 2026, $22.7B in all. 21 of them are rated Elite.
Are institutions buying or selling WST?
Buying, on balance. In Q2 2026, 160 institutions opened or added to positions in WST and 139 institutions trimmed or exited.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer